Contributions of activated CD4 T cells to anti-tumor immunity can be more than just providing the help to CTLs, but also include activation of NK cells and macrophages through IFN-γ, modulation of tumor stroma and angiogenesis or direct cytolytic effects (80–83). The gene discussed is CD4; the disease is neoplasm.